Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
No entries.
Section 2 · machine-generated
Variations
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
Other field of use
Veterinary lung fibrosis research assay
Primary canine lung fibroblasts grow on collagen-coated wells and receive transforming growth factor beta to induce a fibrotic response. Matched wells receive a PGAM–Chk1 binding inhibitor or its vehicle. Chk1 immunoprecipitation followed by PGAM immunoblotting measures complex abundance, and imaging measures alpha-smooth muscle actin in parallel wells.
Component substitution
Antibody fragment as the binding inhibitor
A single-chain antibody fragment directed against the PGAM surface that contacts Chk1 replaces the small-molecule inhibitor in a purified-protein assay. The fragment binds PGAM before purified Chk1 enters the reaction. A Chk1 pull-down measures bound PGAM, with a nonbinding antibody fragment as the control.
Parameter or scale variation
Concentration and exposure time matrix
Human lung fibroblasts occupy matched 96-well plates with eight twofold inhibitor concentrations from 0.078 to 10 micromolar in triplicate. One plate receives a 2-hour exposure and the other receives a 24-hour exposure, with vehicle controls on each plate. A proximity ligation assay measures PGAM–Chk1 signal per nucleus, and parallel wells provide a cell viability measurement.
Combination with existing systems
Perfused kidney model with inhibitor dosing
A two-channel microfluidic device places renal tubular epithelial cells in one channel and renal fibroblasts in a collagen matrix in the other, with a porous membrane between them. A pump delivers medium containing the PGAM–Chk1 binding inhibitor through the epithelial channel while a matched device receives vehicle. Fluorescence imaging measures PGAM–Chk1 proximity in the fibroblast compartment, and an effluent assay measures released procollagen.
Inhibitor testing in precision cut liver slices
A vibrating blade cuts liver tissue into 250-micrometer slices for culture on porous inserts. Adjacent slices from the same tissue block receive a PGAM–Chk1 binding inhibitor or vehicle through the medium beneath the insert. Tissue sections provide spatial measurements of PGAM–Chk1 proximity and alpha-smooth muscle actin, while a tissue ATP assay measures viability in matched slices.
Automated or data-driven variant
Automated imaging of binding inhibition
A liquid handler dispenses serial inhibitor dilutions across a plate of human renal fibroblasts and reserves wells for vehicle and single-antibody controls. An automated microscope captures nuclear, cell-boundary and PGAM–Chk1 proximity ligation images at fixed settings. Image analysis software assigns fluorescent puncta to segmented cells and fits a concentration–response curve to puncta counts after excluding wells below a preset cell-count threshold.
Cite aspatent.fyi, US 2026/0355181 A1, claim 1, first published 2026-11-19T09:07:06-05:00, https://patent.fyi/US20260355181/, SHA-256 70fa1ac71366cc847c982a0262d12939aa3188ed6ef9756c43459c7a1cf8b9f7